PGMN3.SA
Empreendimentos Pague Menos S.A. [PGMN3.SA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PGMN3.SA Stock Summary
Top 10 Correlated ETFs
PGMN3.SA
Top 10 Correlated Stocks
PGMN3.SA
In the News
PGMN3.SA Financial details
Company Rating
-
Market Cap
1.84B
Income
162.91M
Revenue
10.6B
Book val./share
4.82
Cash/share
0.62
Dividend
0.19
Dividend %
5.49%
Employees
20.1K
Optionable
No
Shortable
Yes
Earnings
07 Nov 2023
P/E
9.7
Forward P/E
42.38
PEG
-0.61
P/S
0.17
P/B
0.7
P/C
5.47
P/FCF
335.59
Quick Ratio
0.42
Current Ratio
1.47
Debt / Equity
1.55
LT Debt / Equity
1.3
-
-
EPS (TTM)
-0.22
EPS next Y
0.08
EPS next Q
0.04
EPS this Y
56.76%
EPS next Y
-134.45%
EPS next 5Y
-202.11%
EPS last 5Y
16.52%
Revenue last 5Y
8.03%
Revenue Q/Q
8.26%
EPS Q/Q
-42.86%
-
-
-
-
SMA20
13.96%
SMA50
-9.3%
SMA100
-14.18%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
7%
ROC
0.08%
Gross Margin
32%
Oper. Margin
4%
Profit Margin
2%
Payout
194%
Shs Outstand
539.91M
Shs Float
250.38M
-
-
-
-
Target Price
-
52W Range
2.54-4.712151
52W High
-15.25%
52W Low
+69.5%
RSI
52.11
Rel Volume
0.92
Avg Volume
1.05M
Volume
967.9K
Perf Week
-6.35%
Perf Month
5.28%
Perf Quarter
-6.35%
Perf Half Y
0.89%
-
-
-
-
Beta
0.134
-
-
Volatility
0.09%, 0.19%
Prev Close
0%
Price
3.39
Change
-0.29%
PGMN3.SA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 17.8 | 18.31 | 15.3 | 16.79 | 20.5 | |
| Net income per share | 0.27 | -0.02 | 0.21 | 0.37 | 0.59 | |
| Operating cash flow per share | 0.09 | 0.52 | -0.19 | 0.3 | 0.33 | |
| Free cash flow per share | -0.45 | 0.35 | -0.29 | -0.23 | -0.4 | |
| Cash per share | 0.34 | 0.36 | 1.38 | 1.46 | 0.35 | |
| Book value per share | 2.94 | 2.92 | 4.33 | 4.66 | 5.21 | |
| Tangible book value per share | 2.83 | 2.82 | 4.25 | 4.53 | 1.1 | |
| Share holders equity per share | 2.94 | 2.92 | 4.33 | 4.66 | 5.21 | |
| Interest debt per share | 3.05 | 7.45 | 5.49 | 6.92 | 8.42 | |
| Market cap | 3.65B | 3.65B | 4.04B | 4.19B | 1.93B | |
| Enterprise value | 4.56B | 5.96B | 5.76B | 6.46B | 5.24B | |
| P/E ratio | 39.24 | -525.28 | 42.11 | 25.49 | 7.33 | |
| Price to sales ratio | 0.58 | 0.57 | 0.59 | 0.56 | 0.21 | |
| POCF ratio | 119.82 | 19.94 | -47.69 | 30.73 | 13.16 | |
| PFCF ratio | -23.29 | 29.54 | -30.93 | -39.89 | -10.76 | |
| P/B Ratio | 3.54 | 3.56 | 2.08 | 2.01 | 0.83 | |
| PTB ratio | 3.54 | 3.56 | 2.08 | 2.01 | 0.83 | |
| EV to sales | 0.73 | 0.93 | 0.84 | 0.86 | 0.57 | |
| Enterprise value over EBITDA | 39.85 | 14.76 | 13.76 | 10.59 | 5.83 | |
| EV to operating cash flow | 149.76 | 32.59 | -67.9 | 47.39 | 35.76 | |
| EV to free cash flow | -29.11 | 48.29 | -44.04 | -61.51 | -29.24 | |
| Earnings yield | 0.03 | 0 | 0.02 | 0.04 | 0.14 | |
| Free cash flow yield | -0.04 | 0.03 | -0.03 | -0.03 | -0.09 | |
| Debt to equity | 1 | 2.38 | 1.19 | 1.4 | 1.48 | |
| Debt to assets | 0.3 | 0.51 | 0.4 | 0.45 | 0.44 | |
| Net debt to EBITDA | 7.97 | 5.73 | 4.09 | 3.72 | 3.68 | |
| Current ratio | 1.19 | 1.3 | 1.67 | 1.6 | 1.37 | |
| Interest coverage | 0.16 | 0.85 | 1.05 | 1.91 | 1.65 | |
| Income quality | 0.33 | -26.34 | -0.88 | 0.83 | 0.56 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.23 | |
| Capex to operating cash flow | -6.14 | -0.33 | 0.54 | -1.77 | -2.22 | |
| Capex to revenue | -0.03 | -0.01 | -0.01 | -0.03 | -0.04 | |
| Capex to depreciation | -1.73 | -0.24 | -0.18 | -0.87 | -0.84 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.19 | 1.14 | 4.57 | 6.2 | 8.29 | |
| ROIC | 0.01 | 0.01 | 0.04 | 0.05 | 0.08 | |
| Return on tangible assets | 0.03 | 0 | 0.02 | 0.03 | 0.04 | |
| Graham Net | -3.2 | -7.25 | -3.99 | -5.07 | -8.07 | |
| Working capital | 343.27M | 504.23M | 1.26B | 1.32B | 911.59M | |
| Tangible asset value | 994.3M | 989.37M | 1.9B | 2.03B | 494.97M | |
| Net current asset value | -161.4M | -1.59B | -665.47M | -970.56M | -2.1B | |
| Invested capital | 1 | 2.38 | 1.19 | 1.4 | 1.48 | |
| Average receivables | 480.59M | 487.25M | 621.55M | 751.94M | 757.06M | |
| Average payables | 1.03B | 1.09B | 1.17B | 1.28B | 1.31B | |
| Average inventory | 1.44B | 1.49B | 1.58B | 1.83B | 2.15B | |
| Days sales outstanding | 27.27 | 28.86 | 39.13 | 37.26 | 29.61 | |
| Days payables outstanding | 94.22 | 91.19 | 95.87 | 93.35 | 77.24 | |
| Days of inventory on hand | 131.94 | 121.53 | 131.13 | 139.83 | 137.39 | |
| Receivables turnover | 13.38 | 12.65 | 9.33 | 9.79 | 12.33 | |
| Payables turnover | 3.87 | 4 | 3.81 | 3.91 | 4.73 | |
| Inventory turnover | 2.77 | 3 | 2.78 | 2.61 | 2.66 | |
| ROE | 0.09 | -0.01 | 0.05 | 0.08 | 0.11 | |
| Capex per share | -0.53 | -0.17 | -0.1 | -0.54 | -0.73 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.64 | 5.58 | 0 | 5.9 | 6.08 | |
| Net income per share | 0.12 | 0 | 0 | -0.14 | -0.08 | |
| Operating cash flow per share | 0.12 | 0.34 | 0 | 0.32 | 0.2 | |
| Free cash flow per share | -0.05 | 0.15 | 0 | 0.24 | 0.13 | |
| Cash per share | 0.77 | 0.57 | 0 | 0.29 | 0.62 | |
| Book value per share | 4.87 | 5.05 | 0 | 5.13 | 4.82 | |
| Tangible book value per share | 4.72 | 4.8 | 0 | 4.67 | 4.82 | |
| Share holders equity per share | 4.87 | 5.05 | 0 | 5.13 | 4.82 | |
| Interest debt per share | 6.24 | 7.75 | 0 | 4.37 | 7.72 | |
| Market cap | 1.94B | 2.51B | 0 | 1.38B | 1.89B | |
| Enterprise value | 4.32B | 5.62B | 3.31B | 3.05B | 5.09B | |
| P/E ratio | 9.06 | -2.06K | 0 | -5.47 | -12.66 | |
| Price to sales ratio | 0.94 | 1.01 | 0 | 0.53 | 0.67 | |
| POCF ratio | 36.09 | 16.63 | 0 | 9.62 | 20.54 | |
| PFCF ratio | -88.03 | 37.98 | 0 | 13.09 | 30.11 | |
| P/B Ratio | 0.89 | 1.11 | 0 | 0.6 | 0.84 | |
| PTB ratio | 0.89 | 1.11 | 0 | 0.6 | 0.84 | |
| EV to sales | 2.08 | 2.26 | 1.25 | 1.17 | 1.79 | |
| Enterprise value over EBITDA | 23.69 | 18.59 | 12.1 | 23.67 | 26.32 | |
| EV to operating cash flow | 80.24 | 37.26 | -27.78 | 21.35 | 55.35 | |
| EV to free cash flow | -195.72 | 85.1 | -14.49 | 29.07 | 81.11 | |
| Earnings yield | 0.03 | 0 | 0 | -0.05 | -0.02 | |
| Free cash flow yield | -0.01 | 0.03 | 0 | 0.08 | 0.03 | |
| Debt to equity | 1.25 | 1.49 | 1.48 | 0.79 | 1.55 | |
| Debt to assets | 0.42 | 0.42 | 0.44 | 0.21 | 0.45 | |
| Net debt to EBITDA | 13.03 | 10.29 | 12.1 | 13.01 | 16.55 | |
| Current ratio | 1.55 | 1.47 | 1.37 | 1.42 | 1.47 | |
| Interest coverage | 1.62 | 2.24 | 1.65 | -0.02 | 0.55 | |
| Income quality | 1 | 1.79 | -1.17 | -2.27 | -5.24 | |
| Dividend Yield | 0 | 0 | 0 | 0.06 | 0.12 | |
| Payout ratio | 0 | 0 | 0 | -1.3 | -6.29 | |
| Sales general and administrative to revenue | 0.04 | 0.07 | 0 | 0.04 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.23 | 0.03 | 0.22 | |
| Capex to operating cash flow | -1.41 | -0.56 | 0.92 | -0.27 | -0.32 | |
| Capex to revenue | -0.04 | -0.03 | -0.04 | -0.01 | -0.01 | |
| Capex to depreciation | -0.96 | -0.79 | -0.92 | -0.29 | -0.22 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.63 | 0.28 | 0 | 4.04 | 2.94 | |
| ROIC | 0.02 | 0.02 | 0.03 | 0 | 0.01 | |
| Return on tangible assets | 0.01 | 0 | 0.04 | -0.01 | -0.01 | |
| Graham Net | -5.26 | -9.29 | 0 | -8.81 | -7.6 | |
| Working capital | 1.16B | 1.3B | 911.59M | 1.16B | 1.05B | |
| Tangible asset value | 2.1B | 2.14B | 494.97M | 2.07B | 526.58M | |
| Net current asset value | -1.01B | -1.73B | -2.1B | -2.19B | -2.12B | |
| Invested capital | 1.25 | 1.49 | 1.48 | 0.79 | 1.55 | |
| Average receivables | 749M | 366M | 372.74M | 772.56M | 730.71M | |
| Average payables | 1.24B | 1.44B | 1.49B | 1.46B | 1.39B | |
| Average inventory | 2.01B | 2.42B | 2.57B | 2.69B | 2.6B | |
| Days sales outstanding | 31.82 | 0 | 25.26 | 27.46 | 21 | |
| Days payables outstanding | 80.35 | 86.79 | 65.8 | 79.41 | 55.72 | |
| Days of inventory on hand | 134.71 | 146.72 | 117.04 | 151.23 | 102.71 | |
| Receivables turnover | 2.83 | 0 | 3.56 | 3.28 | 4.29 | |
| Payables turnover | 1.12 | 1.04 | 1.37 | 1.13 | 1.62 | |
| Inventory turnover | 0.67 | 0.61 | 0.77 | 0.6 | 0.88 | |
| ROE | 0.02 | 0 | 0.11 | -0.03 | -0.02 | |
| Capex per share | -0.17 | -0.19 | 0 | -0.09 | -0.06 |
PGMN3.SA Frequently Asked Questions
What is Empreendimentos Pague Menos S.A. stock symbol ?
Empreendimentos Pague Menos S.A. is a BR stock , located in Fortaleza of Ce and trading under the symbol PGMN3.SA
What is Empreendimentos Pague Menos S.A. stock quote today ?
Empreendimentos Pague Menos S.A. stock price is $3.39 today.
Is Empreendimentos Pague Menos S.A. stock public?
Yes, Empreendimentos Pague Menos S.A. is a publicly traded company.
Company Profile
- Volume Average 1.05M
- Market Capitalization 1.84B
- Employee 20.1K
- CEO Mr. Mario Henrique Alves De Queirós
- Headquarters Fortaleza,CE,BR
- IPO Date 2020-09-03
-
Website
https://www.paguemenos.com.br 
Empreendimentos Pague Menos S.A. operates a chain of pharmacies in Brazil. The company offers medicines and health care products in the areas of contraceptive, gastrointestinal and hepatic, allergy, anti-smoking, erectile dysfunction, ophthalmic, intestinal reeducator, pain, fever, inflammation, weight loss, natural soothing, cholesterol and triglyceride, circulation care, dermatological, diabetes, phytotherapies and natural, cold and flu, vitamin and mineral, and osteoporosis. It also provides personal care and beauty products, including absorbent, deodorant, geriatric, intimate care, shower, bleacher, oral hygiene, make up, perfume, and cologne, as well as foot, hair, face, and hand care products; dermo-cosmetics; and repellent, diaper, food, cloth, shower, and oral hygiene products, as well as other accessories for moms and babies. In addition, the company offers toys, clothing and accessories, foods and drinks, utilities, and others; and cereals, fibers, and energetics and isotonic products, as well as operates stationary stores. It operates through a network of 1,105 stores. Empreendimentos Pague Menos S.A. was founded in 1981 and is headquartered in Fortaleza, Brazil.
